| Literature DB >> 34096775 |
Juan A Cantres-Velez1, Justin L Blaize1, David A Vierra1, Rebecca A Boisvert1, Jada L Garzon2, Benjamin Piraino1, Winnie Tan3, Andrew J Deans3, Niall G Howlett1.
Abstract
Fanconi anemia (FA) is a rare genetic disease characterized by increased risk for bone marrow failure and cancer. The FA proteins function together to repair damaged DNA. A central step in the activation of the FA pathway is the monoubiquitination of the FANCD2 and FANCI proteins, which occurs upon exposure to DNA-damaging agents and during the S phase of the cell cycle. The regulatory mechanisms governing S-phase monoubiquitination, in particular, are poorly understood. In this study, we have identified a cyclin-dependent kinase (CDK) regulatory phosphosite (S592) proximal to the site of FANCD2 monoubiquitination. FANCD2 S592 phosphorylation was detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and by immunoblotting with an S592 phospho-specific antibody. Mutation of S592 leads to abrogated monoubiquitination of FANCD2 during the S phase. Furthermore, FA-D2 (FANCD2-/-) patient cells expressing S592 mutants display reduced proliferation under conditions of replication stress and increased mitotic aberrations, including micronuclei and multinucleated cells. Our findings describe a novel cell cycle-specific regulatory mechanism for the FANCD2 protein that promotes mitotic fidelity.Entities:
Keywords: CDK phosphorylation; FANCD2; Fanconi anemia; cell cycle; chromosome stability; ubiquitin; ubiquitination
Mesh:
Substances:
Year: 2021 PMID: 34096775 PMCID: PMC8300791 DOI: 10.1128/MCB.00234-21
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272